Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $1.75 Million - $2.3 Million
-43,447 Reduced 73.06%
16,021 $665,000
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $192,207 - $217,926
-4,006 Reduced 6.31%
59,468 $3.22 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $4.03 Million - $4.81 Million
-83,108 Reduced 56.7%
63,474 $3.26 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $533,166 - $596,163
-9,210 Reduced 5.91%
146,582 $8.51 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $221,838 - $246,316
3,482 Added 2.29%
155,792 $9.96 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $1.02 Million - $1.16 Million
15,594 Added 11.41%
152,310 $10.6 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $4.36 Million - $5.16 Million
63,597 Added 86.98%
136,716 $9.84 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $337 - $199,553
-2,597 Reduced 3.43%
73,119 $5.2 Million
Q2 2022

Sep 06, 2022

BUY
$72.62 - $79.98 $14,741 - $16,235
203 Added 0.27%
75,716 $5.83 Million
Q1 2022

May 25, 2022

BUY
$61.48 - $73.72 $729,337 - $874,540
11,863 Added 18.64%
75,513 $5.52 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $559,789 - $652,583
10,438 Added 19.62%
63,650 $3.97 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $2.58 Million - $3.02 Million
43,589 Added 452.97%
53,212 $3.15 Million
Q1 2021

May 06, 2021

BUY
$59.34 - $66.74 $1,898 - $2,135
32 Added 0.33%
9,623 $607,000
Q4 2020

Feb 18, 2021

SELL
$57.74 - $65.43 $42,843 - $48,549
-742 Reduced 7.18%
9,591 $595,000
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $78,679 - $87,186
1,370 Added 15.29%
10,333 $623,000
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $300,468 - $351,277
-5,481 Reduced 37.95%
8,963 $527,000
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $90,712 - $131,825
-1,955 Reduced 11.92%
14,444 $805,000
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $9,103 - $11,875
185 Added 1.14%
16,399 $1.05 Million
Q3 2019

Nov 04, 2019

BUY
$42.77 - $50.71 $66,935 - $79,361
1,565 Added 10.68%
16,214 $822,000
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $25,433 - $28,123
570 Added 4.05%
14,649 $664,000
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $902 - $1,076
20 Added 0.14%
14,079 $672,000
Q4 2018

Jan 23, 2019

BUY
$48.76 - $63.23 $685,516 - $888,950
14,059 New
14,059 $731,000
Q4 2018

Jan 22, 2019

SELL
$48.76 - $63.23 $661,136 - $857,335
-13,559 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$55.19 - $62.25 $33,058 - $37,287
-599 Reduced 4.23%
13,559 $842,000
Q2 2018

Jul 12, 2018

SELL
$50.53 - $62.98 $29,863 - $37,221
-591 Reduced 4.01%
14,158 $783,000
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $95,872 - $110,368
-1,600 Reduced 9.79%
14,749 $933,000
Q4 2017

Feb 05, 2018

BUY
$59.94 - $65.35 $979,959 - $1.07 Million
16,349
16,349 $1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.